Tankrich

Tankrich

Suven Life sciences - Demerger to create Value?

Jul 23, 2019
∙ Paid
Share

Suven Life sciences is a company that I am tracking from 2014 This is what I wrote in 2014 on their optionality But as you would have seen expecting the company to not to commercialize any R&D work for 18 years would be a real surprise In 2015, I noted the possibility of monetizing their lead molecule in 2017 SUVN 502. For this molecule, we completed Ph…

Keep reading with a 7-day free trial

Subscribe to Tankrich to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Vivek Bothra
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture